publication

Differential pathogenicity of three major Mycobacterium avium complex species causing pulmonary disease: a systematic review and meta-analysis

Abstract

Background: Mycobacterium avium complex (MAC) species are the leading causes of nontuberculous mycobacterial pulmonary disease worldwide. However, the clinical relevance and species-specific manifestations of MAC pulmonary disease (MAC-PD) caused by M. avium, M. intracellulare and M. chimaera remain incompletely understood.

Objective: To compare the clinical relevance, radiological manifestations and treatment outcomes associated with M. avium, M. intracellulare and M. chimaera pulmonary disease.

Methods: We performed a systematic review and meta-analysis of studies published between 2006 and 2 March 2026, identified through PubMed, Embase and Web of Science. Studies reporting adult patients with pulmonary isolates of M. avium, M. intracellulare or M. chimaera were included. Random-effects meta-analyses were conducted to estimate pooled proportions for clinical relevance, radiological manifestations, treatment success, culture conversion, relapse and mortality.

Results: A total of 134 studies comprising 46,980 patients were included, of whom 28,858 had M. avium, 17,540 had M. intracellulare and 582 had M. chimaera. Clinical relevance was comparable for M. avium and M. intracellulare (53.8% versus 54.7%) but lower for M. chimaera (17.8%). Nodular bronchiectatic disease predominated across all species. Treatment success (63.0–67.5%), culture conversion (70.8–71.9%), relapse (27.9–29.1%) and mortality (14.2–19.3%) were similar between M. avium and M. intracellulare. However, patients with M. chimaera were less frequently treated.

Conclusions: M. avium and M. intracellulare were associated with comparable clinical relevance, disease manifestations and treatment outcomes across geographic regions, whereas M. chimaera was associated with less clinically relevant disease. Improved molecular species differentiation may further clarify species-specific pathogenicity and clinical implications in MAC-PD.